Published in Leukemia on September 01, 1990
Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood (2012) 1.23
Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med (2004) 1.22
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome. Blood (2008) 1.18
Expression of Toll-like receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis. Respir Res (2007) 1.01
Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives. Blood (2016) 0.94
Consistent quantitative gene product expression: #2. Antigen intensities on bone marrow cells are invariant between individuals. Cytometry A (2016) 0.92
The adult livers of immunodeficient mice support human hematopoiesis: evidence for a hepatic mast cell population that develops early in human ontogeny. PLoS One (2014) 0.83
Growth factor independence 1 (Gfi1) regulates cell-fate decision of a bipotential granulocytic-monocytic precursor defined by expression of Gfi1 and CD48. Am J Blood Res (2012) 0.80
Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias. Int J Clin Exp Pathol (2012) 0.80
Circulating promyelocytes and low levels of CD16 expression on polymorphonuclear leukocytes accompany early-onset periodontitis. Infect Immun (1997) 0.79
Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow. Leukemia (2015) 0.79
A late-lineage murine neutrophil precursor population exhibits dynamic changes during demand-adapted granulopoiesis. Sci Rep (2017) 0.75
The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis. ScientificWorldJournal (2011) 0.75
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol (1986) 5.27
Analysis of cell populations with a fluorescence-activated cell sorter. Ann N Y Acad Sci (1975) 3.76
Onset of DNA synthesis during the cell cycle in chemostat cultures. Proc Natl Acad Sci U S A (1967) 3.70
Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood (1991) 3.12
Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol Rev (1982) 3.06
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol (2001) 2.71
Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med (1990) 2.33
Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies. J Immunol (1984) 2.16
Performance status of health care facilities changes with risk adjustment of HbA1c. Diabetes Care (2000) 2.06
Murine T lymphocyte clones with distinct immunological functions. Immunol Rev (1981) 1.79
Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood (1990) 1.76
Two-color immunofluorescence using a fluorescence-activated cell sorter. J Histochem Cytochem (1977) 1.67
Expression of IgD by murine lymphocytes. Loss of surface IgD indicates maturation of memory B cells. J Exp Med (1978) 1.60
Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood (1987) 1.60
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57
A clone-specific monoclonal antibody that inhibits cytolysis of a cytolytic T cell clone. J Exp Med (1983) 1.48
Lyt-2-/Lyt 3- variants of a cloned cytolytic T cell line lack an antigen receptor functional in cytolysis. J Exp Med (1981) 1.44
A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol (1998) 1.43
Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome. Leuk Lymphoma (2000) 1.36
Surface markers and functional relationships of cells involved in murine B-lymphocyte differentiation. Cold Spring Harb Symp Quant Biol (1977) 1.32
Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. J Immunol (1988) 1.29
Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis. Blood (2001) 1.28
Constancy of cell buoyant density for cultured murine cells. J Cell Physiol (1984) 1.24
I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. J Immunol (1982) 1.23
Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression. J Immunol (1984) 1.21
Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. Am J Clin Pathol (1998) 1.20
Interaction between I region loci influences the expression of a cell surface Ia antigen. Proc Natl Acad Sci U S A (1980) 1.20
Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol (1987) 1.19
Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J Leukoc Biol (1990) 1.16
Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells. Hybridoma (1981) 1.15
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia (2002) 1.14
Monoclonal antibodies to rabbit lymphoid cells: preparation and characterization of a T-cell-specific antibody. Mol Immunol (1981) 1.12
Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. Bone Marrow Transplant (2007) 1.11
Routine quantitation of white cells as low as 0.001 per microL in platelet components. Transfusion (1993) 1.06
Simultaneous analysis of cell surface antigens, bromodeoxyuridine incorporation and DNA content. Cytometry (1985) 1.02
CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci (1993) 1.01
High molecular weight lymphocyte surface proteins are structurally related and are expressed on different cell populations at different times during lymphocyte maturation and differentiation. J Immunol (1982) 1.01
Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. J Natl Cancer Inst (1996) 1.00
Antigenic analysis of hematopoiesis. IV. The My-11 hematopoietic cell surface antigen is expressed by myelomonocytic and lymphoid, but not erythroid, progenitor cells. Exp Hematol (1986) 1.00
Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol (1990) 1.00
Flow cytometry as an analytical and preparative tool in immunology. J Immunol Methods (1982) 0.99
Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood (1988) 0.99
Clonal evolution of myeloma cells leads to quantitative changes in immunoglobulin secretion and surface antigen expression. Proc Natl Acad Sci U S A (1979) 0.97
Excited-state proton transfer as a biological probe. Determination of rate constants by means of nanosecond fluorometry. Biochemistry (1972) 0.97
Multiparameter flow cytometric analysis of human fetal bone marrow B cells. Leukemia (1990) 0.97
Simultaneous quantitation of Hoechst 33342 and immunofluorescence on viable cells using a fluorescence activated cell sorter. Cytometry (1980) 0.95
Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. Int J Cell Cloning (1987) 0.95
Separation of viable T and B lymphocytes using a cytochemical stain, Hoechst 33342. J Histochem Cytochem (1980) 0.95
Cell discrimination by multiangle light scattering. J Histochem Cytochem (1976) 0.92
Multidimensional flow cytometric blood cell differentiation without erythrocyte lysis. Blood Cells (1991) 0.92
Effect of ethanol on functions required for the delivery of neutrophils to sites of inflammation. J Infect Dis (1988) 0.91
DNL 1.9: a monoclonal antibody which specifically detects all murine B lineage cells. Eur J Immunol (1981) 0.90
Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow. Blood (1988) 0.89
Increased light scattering resolution facilitates multidimensional flow cytometric analysis. Cytometry (1990) 0.88
Alteration of clonal profile. II. Studies on the capacity of BALB/c splenic B cells to perpetuate responsiveness to phosphorylcholine and T 15 idiotypic dominance. Eur J Immunol (1981) 0.88
A rapid sample preparation technique for flow cytometric analysis of immunofluorescence allowing absolute enumeration of cell subpopulations. J Immunol Methods (1989) 0.88
Insulin resistance and weight gain in postmenopausal women of diverse ethnic groups. Int J Obes Relat Metab Disord (2004) 0.87
Somatic mutations in the HLA genes of patients with hematological malignancy. Tissue Antigens (2012) 0.87
Three-color immunofluorescence analysis of Leu antigens on human peripheral blood using two lasers on a fluorescence-activated cell sorter. Cytometry (1984) 0.86
Identification of cell asymmetry and orientation by light scattering. J Histochem Cytochem (1977) 0.86
Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell. Blood (2000) 0.86
Human "null" cells mediating antibody-dependent cellular cytotoxicity express T lymphocyte differentiation antigens. J Immunol (1980) 0.85
S-phase detection with an antibody to bromodeoxyuridine. Role of DNase pretreatment. J Immunol Methods (1986) 0.85
Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia (1992) 0.85
Positive stem cell selection--basic science. Prog Clin Biol Res (1990) 0.84
The skin test antigen stimulated killer (STAK) cell mediating NK like CMC is OKM1 positive and OKT3 negative. Clin Exp Immunol (1983) 0.84
Single laser three color immunofluorescence staining procedures based on energy transfer between phycoerythrin and cyanine 5. Cytometry (1991) 0.84
Inhibition of proliferation of MIs- and Ia-reactive cloned T cells by a monoclonal antibody against a determinant shared by I-A and I-E. J Immunol (1983) 0.83
Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties. Leukemia (1991) 0.83
Time-dependent resistance or susceptibility of tumor cells to cytotoxic antibody after exposure to a chemotherapeutic agent. Proc Natl Acad Sci U S A (1978) 0.83
Quantitative fluorescence analysis of cyclosporine binding to human leukocytes. Transplantation (1984) 0.83
Two color light scattering identifies physical differences between lymphocyte subpopulations. Cytometry (1982) 0.82
The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry. Am J Clin Pathol (1999) 0.82
Graft-versus-leukemia effect in acute lymphoblastic leukemia: the importance of tumor burden and early detection. Leukemia (2004) 0.80
Heritable and non-heritable variations in the phenotype of myeloma cells as detected by a fluorescence-activated cell sorter. J Histochem Cytochem (1979) 0.80
Five-dimensional flow cytometry as a new approach for blood and bone marrow differentials. Cytometry (1988) 0.80
Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia (1992) 0.79
Allotypes of mouse IgM immunoglobulin. Nature (1977) 0.79
Direct determination of the influence of the cell cycle on the survival of tumor cells exposed to cytotoxic antibodies. Cancer Res (1980) 0.79
Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry (1988) 0.79
Bone marrow cell differential counts obtained by multidimensional flow cytometry. Blood Cells (1992) 0.79
Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation. Int J Lab Hematol (2013) 0.79
Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis. Blood (1996) 0.78
Characterization of functionally distinct subpopulations of rabbit T lymphocytes. Immunology (1984) 0.78
Changes in susceptibility to cytotoxic antibody among tumor cells surviving exposure to chemotherapeutic agents. Cancer Res (1982) 0.78
Analysis of human lymphocyte protein expression. I. Identification of subpopulation markers by two-dimensional polyacrylamide gel electrophoresis. Eur J Immunol (1988) 0.77
Simultaneous analysis of DNA content and surface antigens in human bone marrow. Cytometry (1988) 0.77
Oral cancer and oral effects of anticancer therapy. Mt Sinai J Med (1998) 0.77
Detection of minimal residual disease in acute myelogenous leukemia. J Pediatr Hematol Oncol (1995) 0.76
Characterization of murine hemopoietic cells using rat anti-mouse monoclonal antibodies. Hybridoma (1983) 0.76
T15 idiotype expression in the murine response to phosphorylcholine is actively regulated by genes linked to the Igh-C locus. J Immunol (1986) 0.76
Nonrandom escape of tumor cells from immune lysis due to intraclonal fluctuations in antigen expression. Cancer Res (1983) 0.76
Two B-cell subpopulations identified by flow cytometry. Immunology (1985) 0.75